MSH2 and cancer: To illustrate the importance of having specific penetrance estimates for the HNPCC families in Newfoundland (NL), we estimated both the probability of being a MSH2 mutation carrier and the probability of developing CRC and EC in cancer-free individuals in Family 1 from our sample.